Clinical Trials Browser

CTIT: Cancer Therapy Induced Thrombocytopenia

NCT07410117 2026-04-09

ROXI-CAT-I

Phase 3 Recruiting

860 enrolled

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05198960 2026-03-20

AVAJAK

Phase 3 Recruiting

1,308 enrolled

Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06499285 2026-03-11

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Phase 3 Recruiting

225 enrolled

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

996 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06861088 2026-02-02

CATIQ P3

Phase 3 Recruiting

480 enrolled

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

1,828 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT05407987 2025-04-25

FORGE II

Phase 3 Recruiting

82 enrolled

Classical hematology

Anemia, Anemia, Iron-Deficiency

Clinical Trials

FRIENDS-01

ROXI-CAT-I

AVAJAK

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

DOAC

CATIQ P3

TRIM-Line

FORGE II